ScoreWhy is Aarey Drugs & Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with a -6.27% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.40
- The company has been able to generate a Return on Equity (avg) of 3.75% signifying low profitability per unit of shareholders funds
- NET SALES(Q) At Rs 44.63 cr has Fallen at -56.33%
- PBT LESS OI(Q) At Rs -1.20 cr has Fallen at -766.67%
- NON-OPERATING INCOME(Q) is 330.77 % of Profit Before Tax (PBT)
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Aarey Drugs for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Aarey Drugs
39.1%
0.74
52.99%
Sensex
-4.28%
-0.32
13.44%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.46%
EBIT Growth (5y)
-6.27%
EBIT to Interest (avg)
1.40
Debt to EBITDA (avg)
7.16
Net Debt to Equity (avg)
0.32
Sales to Capital Employed (avg)
2.81
Tax Ratio
0.48%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.43%
ROCE (avg)
2.55%
ROE (avg)
3.75%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
60
Industry P/E
21
Price to Book Value
1.66
EV to EBIT
83.32
EV to EBITDA
43.86
EV to Capital Employed
1.50
EV to Sales
0.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.17%
ROE (Latest)
2.77%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 3.64 times
-8What is not working for the Company
NET SALES(Q)
At Rs 44.63 cr has Fallen at -56.33%
PBT LESS OI(Q)
At Rs -1.20 cr has Fallen at -766.67%
NON-OPERATING INCOME(Q)
is 330.77 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Aarey Drugs
Debtors Turnover Ratio- Half Yearly
Highest at 3.64 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Aarey Drugs
Net Sales - Quarterly
At Rs 44.63 cr has Fallen at -56.33%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.20 cr has Fallen at -766.67%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 44.63 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Non Operating Income - Quarterly
is 330.77 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
